-transparent.png){kind=logo}
These results suggest (1) that ALS + BM fractions can be used to promote tolerance in long-term graft survivors; (2) that the presence of apparent BM cells of donor origin in the allograft in normally functioning kidneys may be related to the mechanism of allograft prolongation, and (3) that some promise of possible specific long-term immunosuppression exists clinically.
Related Publications
W C Hartner, and
S R De Fazio, and
T G Markees, and
T Maki, and
A P Monaco, and
J J Gozzo
January 1999,
Transplantation proceedings,
W C Hartner, and
S R De Fazio, and
T G Markees, and
T Maki, and
A P Monaco, and
J J Gozzo
April 1972,
The British journal of surgery,
W C Hartner, and
S R De Fazio, and
T G Markees, and
T Maki, and
A P Monaco, and
J J Gozzo
March 1992,
Transplantation,
W C Hartner, and
S R De Fazio, and
T G Markees, and
T Maki, and
A P Monaco, and
J J Gozzo
January 1975,
Advances in nephrology from the Necker Hospital,
W C Hartner, and
S R De Fazio, and
T G Markees, and
T Maki, and
A P Monaco, and
J J Gozzo
April 1990,
Transplantation proceedings,
W C Hartner, and
S R De Fazio, and
T G Markees, and
T Maki, and
A P Monaco, and
J J Gozzo
August 1991,
Transplantation proceedings,
W C Hartner, and
S R De Fazio, and
T G Markees, and
T Maki, and
A P Monaco, and
J J Gozzo
February 1987,
Transplantation proceedings,
W C Hartner, and
S R De Fazio, and
T G Markees, and
T Maki, and
A P Monaco, and
J J Gozzo
August 1998,
Transplantation proceedings,
W C Hartner, and
S R De Fazio, and
T G Markees, and
T Maki, and
A P Monaco, and
J J Gozzo
December 1995,
Transplantation proceedings,
W C Hartner, and
S R De Fazio, and
T G Markees, and
T Maki, and
A P Monaco, and
J J Gozzo
June 2004,
Blood,
